Lymphatic Filariasis Program

  

  Lymphatic Filariasis  Program (According to Annual Report 2075/76, DoHS, Nepal)

Ø Lymphatic filariasis mapping was completed in 2005 and remapping in 2012 by ICT (immunochromatography).

Ø EDCD has formulated a national plan of action (2003-2020) for elimination of lymphatic filariasis in Nepal.

Ø 2003 AD: Government had initiated Mass Drug Admission (MDA) in parsa district.

Ø 61 districts are endemic from lymphatic filariasis.

Ø 25 millionpopulations are at risk for LF in 60 indemic districts.

Ø Mass Drug Admission (MDA) stopped in 25 districts

Ø The average prevalence of Lymphatic Filariasis is 13%.

Ø Goal: People of Nepal no longer suffer from LF.

 

Ø Objectives

•    To eliminate LF as a public health problem by 2020

•    To interrupt the transmission of LF

•    To reduce and prevent morbidity

•    To provide deworming benefit through use of Albendazole to endemic community especially to children

•    To reduce mosquito vectors through application of suitable and available vector control strategies (Integrated Vector Management)

Ø Target

•    To scale up MDA to all LF endemic districts by 2014

•    Achieve <1% prevalence (microfilaraemia rate) in all endemic districts after 6 years of MDA by 2018

Ø Terai areas are highly endemic than hilly areas.

Ø The disease has been detected in different topographical areas ranging in altitude from 300 feet sea level in the plain terai ecological zone to 5800 feet above the sea level in hilly areas.